News Anteris Technologies Ltd

Equities

AVR

AU0000088841

Market Closed - Australian S.E. Other stock markets 01:59:02 2024-04-18 am EDT			5-day change	1st Jan Change
23.39 ^AUD	+0.91%		-0.47%	+22.14%

05:19am	Anteris Technologies Posts AU$10.6 Million Cash, AU$20.2 Million Net Cash Outflows for Quarter Ended March 31	MT
Apr. 10	Anteris Technologies Raises AU$23 Million for DurAVR Study	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Anteris Technologies Posts AU$10.6 Million Cash, AU$20.2 Million Net Cash Outflows for Quarter Ended March 31	11:19pm	MT
Anteris Technologies Raises AU$23 Million for DurAVR Study	Apr. 09	MT
Anteris Declares Upbeat Results from Human Trials of Heart Valve	Mar. 13	MT
Anteris Technologies Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Anteris talks market superiority of its biomimetic TAVR valve	23-10-31	AQ
Anteris Technologies Completes Enrollment for Heart Valve Device Study	23-10-17	MT
Anteris Technologies Secures AU$1 Million Tax Rebate for 2022	23-10-12	MT
Anteris Technologies Ltd(ASX:AVR) dropped from S&P Global BMI Index	23-09-18	CI
Anteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023	23-09-12	BU
Anteris Technologies Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Anteris Technologies Ltd - DurAVR Demonstrates Exceptional Results in Second Valve-in-Valve Case	23-08-15	AQ
DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case	23-08-14	BU
Anteris Technologies Ltd Announces DurAVR THV Demonstrates Exceptional Results in Second Valve-in-Valve Case	23-08-14	CI
Anteris Technologies Ltd - Montefiore Health System Enrolls Patients in the US Early Feasibility Study	23-08-10	AQ
Anteris Technologies Commences American Depository Receipt Program	23-08-09	BU
Anteris Technologies Commences US Early Feasibility Study	23-08-09	BU
Montefiore Enrolls Patients for US Early Feasibility Study for Anteris Technologies' DurAVR THV	23-08-09	MT
Anteris welcomes successful DurAVR valve-in-valve procedure	23-08-01	AQ
Anteris Technologies Ltd - First Successful Implantation of DurAVR THV in a Valve-in-Valve Procedure	23-08-01	AQ
Anteris Technologies Announces First Successful Implantation of DurAVR™ THV in a Valve-in-Valve Procedure	23-07-31	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Anteris Technologies Ltd

Equities

AVR

AU0000088841

Summary

Filters